Verona Pharma Hosts Investor and Analyst R&D Forum 2019
Click this link to register and listen to the insightful podcast from Verona Pharma’s Investor and Analyst R&D Day forum 2019
Artios Pharma
Continuing Cambridge’s tradition as a centre of excellence for DNA Damage Response with leading next generation programmes.
Podcast with Joe Anderson CEO of Arix Bioscience
Arix Bioscience (ARIX) CEO Joe Anderson talked to VoxMarkets about investing in and building breakthrough biotech companies to market.
Anglonordic Life Science Conference 2019
Only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK
Company creation and early-stage investing in life sciences: A Novo Seeds perspective
Stephan Christgau, Senior Partner
Novo Seeds.
